Wnt-2



Wnt-2

S1SS1W2WW2W3WW3Y4YY4M5MM5R6RR6A7AA7T8TT8G9GG9G10GG10S11SS11S12SS12R13RR13V14VV14M15MM15C16CC16D17DD17N18NN18V19VV19P20PP20G21GG21L22LL22V23VV23S24SS24S25SS25Q26QQ26R27RR27Q28QQ28L29LL29C30CC30H31HH31R32RR32H33HH33P34PP34D35DD35V36VV36M37MM37R38RR38A39AA39I40II40S41SS41Q42QQ42G43GG43V44VV44A45AA45E46EE46W47WW47... and 288 more residue(s)...... and 288 more residue(s)

SMILES None
InChIKey None
Sequence SWWYMRATGGSSRVMCDNVPGLVSSQRQLCHRHPDVMRAISQGVAEWTAECQHQFRQHRWNCNTLDRDHSLFGRVLLRSSRESAFVYAISSAGVVFAITRACSQGEVKSCSCDPKKMGSAKDSKGIFDWGGCSDNIDYGIKFARAFVDAKERKGKDARALMNLHNNRAGRKAVKRFLKQECKCHGVSGSCTLRTCWLAMADFRKTGDYLWRKYNGAIQVVMNQDGTGFTVANERFKKPTKNDLVYFENSPDYCIRDREAGSLGTAGRVCNLTSRGMDSCEVMCCGRGYDTSHVTRMTKCGCKFHWCCAVRCQDCLEALDVHTCKAPKNADWTTAT

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

Wnt-2

S1SS1W2WW2W3WW3Y4YY4M5MM5R6RR6A7AA7T8TT8G9GG9G10GG10S11SS11S12SS12R13RR13V14VV14M15MM15C16CC16D17DD17N18NN18V19VV19P20PP20G21GG21L22LL22V23VV23S24SS24S25SS25Q26QQ26R27RR27Q28QQ28L29LL29C30CC30H31HH31R32RR32H33HH33P34PP34D35DD35V36VV36M37MM37R38RR38A39AA39I40II40S41SS41Q42QQ42G43GG43V44VV44A45AA45E46EE46W47WW47... and 288 more residue(s)...... and 288 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.